News · 7 March 2026
Study says weight-loss jab can be $3 monthly
Photo by Total Shape on Unsplash
Access to a crucial weight-loss drug could vastly improve for millions globally, as new research suggests a substantial cost reduction. The injectable form of semaglutide, an essential medicine designated by the World Health Organization, might be produced for just $3 each month. This finding comes from a pre-print analysis, revealing patents are expiring in several countries from March 21.
Reported by Guardian · How we write briefs